• Je něco špatně v tomto záznamu ?

Pilot study of sole conformal peroperative interstitial brachyradiotherapy of early stage breast carcinoma using high-dose rate afterloading

P. Šlampa, R. Soumarová, J. Růžičková, V. Chrenko, V. Fait, R. Bartlová, H. Tichá, J. Žaloudík

. 2005 ; 52 (4) : 292-306.

Jazyk angličtina Země Slovensko

Perzistentní odkaz   https://www.medvik.cz/link/bmc10014990

Grantová podpora
NC7108 MZ0 CEP - Centrální evidence projektů

In this study of high-dose-rate brachyradiotherapy to the lumpectomy site as the sole radiation are documented a three-dimensional treatment planning and preliminary results of accelerated partial- breast irradiation. From March 2002 to July 2004 25 patients were prospectively included in this study. Six patients were excluded becuase of definitive histology of lobular carcinoma or positive margin. The median age was 63.2 years (range: 44-77 years). Median follow-up of all patients is 11 months (range: 3-25 months) with a minimum follow-up of 3 months. Radiation was delivered using the high-dose-rate remote afterloader VariSource with [192]Ir source. The patients received radiation twice a day at least 6 hours apart for a total of 10 fractions over five days with a single dose of 3.4 Gy. The total dose was 34.0 Gy prescribed as a minimum peripheral dose to match or minimally exceed the volume defined by the surgical clips as seen on CT scans. Freehand technique allows conformal placement of the catheters to the shape of the lumpectomy cavity. We use the method of geometric optimalisation which allows the calculations of dose distribution in relation to target. At a median follow-up of 11 months none of patients developed in-field breast recurrences, one patient had out-of-field recurrences. There were no regional nodal recurrences. At each patient, there was calculated target volume size in cm3 (median 91.3 cm3) dose volume histogram (DVH), dose homogenity index (DHI). Median DHI was 0.42. Median volume of breast tissue getting 100% of the prescription dose, V(100), is 87%; and V(150) 48.5%. We have noticed two treatment complications: hematoma and abscess in the place of tumorous bed after exstirpation. At last follow-up, patients rated the overall cosmetic outcome excellent. This method is suitable just for patients with histologically confirmed small tumors (<3 cm in diameter) without negative prognostic factors for local recurrence (age at least 40 years, negative surgical margins, nodal involvement - maximum three positive nodes without extracapsular extension).

000      
03681naa 2200445 a 4500
001      
bmc10014990
003      
CZ-PrNML
005      
20121114130553.0
008      
100623s2005 xo e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xo
100    1_
$a Šlampa, Pavel, $d 1960- $7 mzk2004257405
245    10
$a Pilot study of sole conformal peroperative interstitial brachyradiotherapy of early stage breast carcinoma using high-dose rate afterloading / $c P. Šlampa, R. Soumarová, J. Růžičková, V. Chrenko, V. Fait, R. Bartlová, H. Tichá, J. Žaloudík
314    __
$a Department of Radiation Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic slampa@mou.cz
520    9_
$a In this study of high-dose-rate brachyradiotherapy to the lumpectomy site as the sole radiation are documented a three-dimensional treatment planning and preliminary results of accelerated partial- breast irradiation. From March 2002 to July 2004 25 patients were prospectively included in this study. Six patients were excluded becuase of definitive histology of lobular carcinoma or positive margin. The median age was 63.2 years (range: 44-77 years). Median follow-up of all patients is 11 months (range: 3-25 months) with a minimum follow-up of 3 months. Radiation was delivered using the high-dose-rate remote afterloader VariSource with [192]Ir source. The patients received radiation twice a day at least 6 hours apart for a total of 10 fractions over five days with a single dose of 3.4 Gy. The total dose was 34.0 Gy prescribed as a minimum peripheral dose to match or minimally exceed the volume defined by the surgical clips as seen on CT scans. Freehand technique allows conformal placement of the catheters to the shape of the lumpectomy cavity. We use the method of geometric optimalisation which allows the calculations of dose distribution in relation to target. At a median follow-up of 11 months none of patients developed in-field breast recurrences, one patient had out-of-field recurrences. There were no regional nodal recurrences. At each patient, there was calculated target volume size in cm3 (median 91.3 cm3) dose volume histogram (DVH), dose homogenity index (DHI). Median DHI was 0.42. Median volume of breast tissue getting 100% of the prescription dose, V(100), is 87%; and V(150) 48.5%. We have noticed two treatment complications: hematoma and abscess in the place of tumorous bed after exstirpation. At last follow-up, patients rated the overall cosmetic outcome excellent. This method is suitable just for patients with histologically confirmed small tumors (<3 cm in diameter) without negative prognostic factors for local recurrence (age at least 40 years, negative surgical margins, nodal involvement - maximum three positive nodes without extracapsular extension).
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a brachyterapie $x metody $7 D001918
650    _2
$a nádory prsu $x radioterapie $7 D001943
650    _2
$a lobulární karcinom $x radioterapie $7 D018275
650    _2
$a frakcionace dávky záření $7 D019583
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prognóza $7 D011379
650    _2
$a prospektivní studie $7 D011446
650    _2
$a konformní radioterapie $x metody $7 D020266
650    _2
$a výsledek terapie $7 D016896
650    _2
$a financování organizované $7 D005381
650    _2
$a klinické zkoušky jako téma $7 D002986
700    1_
$a Soumarová, Renata $7 xx0031806
700    1_
$a Růžičková, Jana $7 xx0061124
700    1_
$a Chrenko, Vojtěch, $d 1950- $7 xx0061125
700    1_
$a Fait, Vuk $7 xx0053339
700    1_
$a Bartlová, Radka $7 xx0061126
700    1_
$a Tichá, Hana $7 xx0173604
700    1_
$a Žaloudík, Jan, $d 1954- $7 nlk20000083399
773    0_
$t Neoplasma $w MED00003470 $g Roč. 52, č. 4 (2005), s. 292-306 $x 0028-2685
910    __
$a ABA008 $b A 1194 $y 8
990    __
$a 20100623130833 $b ABA008
991    __
$a 20121114130609 $b ABA008
999    __
$a ok $b bmc $g 750858 $s 614536
BAS    __
$a 3
BMC    __
$a 2005 $b 52 $c 4 $d 292-306 $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470
GRA    __
$a NC7108 $p MZ0
LZP    __
$a 2010-B1/mkme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...